

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.33159993 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.32147860 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32147860 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.16028884 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.16028884 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.14016520 |
| 7 | complement activation, alternative pathway (GO:0006957) | 3.82227061 |
| 8 | glutamate secretion (GO:0014047) | 3.81677649 |
| 9 | gamma-aminobutyric acid transport (GO:0015812) | 3.72019006 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.68783498 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 3.68017404 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.64655615 |
| 13 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58651005 |
| 14 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58651005 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 3.56178800 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.55428308 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.54742062 |
| 18 | neurotransmitter secretion (GO:0007269) | 3.53198234 |
| 19 | locomotory exploration behavior (GO:0035641) | 3.52065129 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.49389321 |
| 21 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48216284 |
| 22 | glutamate metabolic process (GO:0006536) | 3.37168739 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 3.35295385 |
| 24 | glycine transport (GO:0015816) | 3.34701731 |
| 25 | bile acid biosynthetic process (GO:0006699) | 3.32632806 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.30271851 |
| 27 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.30243577 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.30243577 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 3.28745685 |
| 30 | glycosphingolipid catabolic process (GO:0046479) | 3.27139030 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.26277919 |
| 32 | glyoxylate metabolic process (GO:0046487) | 3.24412029 |
| 33 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.23888769 |
| 34 | vocalization behavior (GO:0071625) | 3.23138234 |
| 35 | dicarboxylic acid catabolic process (GO:0043649) | 3.21386461 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20913505 |
| 37 | blood coagulation, intrinsic pathway (GO:0007597) | 3.19963598 |
| 38 | lysine metabolic process (GO:0006553) | 3.19124054 |
| 39 | lysine catabolic process (GO:0006554) | 3.19124054 |
| 40 | regulation of superoxide anion generation (GO:0032928) | 3.17110804 |
| 41 | kynurenine metabolic process (GO:0070189) | 3.16999536 |
| 42 | cell communication by electrical coupling (GO:0010644) | 3.16775397 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.16290856 |
| 44 | respiratory electron transport chain (GO:0022904) | 3.15430022 |
| 45 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.13321647 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.10988276 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10140671 |
| 48 | electron transport chain (GO:0022900) | 3.08902926 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.08235957 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.06438870 |
| 51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.04122210 |
| 52 | response to thyroid hormone (GO:0097066) | 3.02887814 |
| 53 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.00952244 |
| 54 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.00359302 |
| 55 | short-chain fatty acid metabolic process (GO:0046459) | 2.99868183 |
| 56 | cellular response to cadmium ion (GO:0071276) | 2.98421785 |
| 57 | * neuromuscular process controlling posture (GO:0050884) | 2.98186397 |
| 58 | sodium ion export (GO:0071436) | 2.98007212 |
| 59 | fibrinolysis (GO:0042730) | 2.96885235 |
| 60 | tryptophan catabolic process (GO:0006569) | 2.95617931 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 2.95617931 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 2.95617931 |
| 63 | neurotransmitter transport (GO:0006836) | 2.92715372 |
| 64 | regulation of macrophage chemotaxis (GO:0010758) | 2.91141361 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 2.90816240 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 2.90563528 |
| 67 | negative regulation of sterol transport (GO:0032372) | 2.90563528 |
| 68 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.89304172 |
| 69 | ketone body metabolic process (GO:1902224) | 2.88558546 |
| 70 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87908143 |
| 71 | glycolipid catabolic process (GO:0019377) | 2.87663266 |
| 72 | coenzyme catabolic process (GO:0009109) | 2.86788773 |
| 73 | regulation of mononuclear cell migration (GO:0071675) | 2.86478955 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 2.83684690 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83655241 |
| 76 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.83555034 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.83555034 |
| 78 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83275421 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83264747 |
| 80 | phospholipid efflux (GO:0033700) | 2.83099658 |
| 81 | acute-phase response (GO:0006953) | 2.82065706 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 2.81608182 |
| 83 | regulation of neurotransmitter levels (GO:0001505) | 2.81340797 |
| 84 | sulfur amino acid catabolic process (GO:0000098) | 2.80864661 |
| 85 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.80224563 |
| 86 | regulation of synapse structural plasticity (GO:0051823) | 2.79439275 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 2.78987468 |
| 88 | protein-lipid complex remodeling (GO:0034368) | 2.78987468 |
| 89 | alpha-amino acid catabolic process (GO:1901606) | 2.78536128 |
| 90 | protein carboxylation (GO:0018214) | 2.78000161 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.78000161 |
| 92 | protein localization to synapse (GO:0035418) | 2.77192987 |
| 93 | succinate metabolic process (GO:0006105) | 2.75872174 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 2.74984003 |
| 95 | regulation of protein activation cascade (GO:2000257) | 2.71608317 |
| 96 | oligosaccharide catabolic process (GO:0009313) | 2.71301144 |
| 97 | bile acid metabolic process (GO:0008206) | 2.70802874 |
| 98 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.69416750 |
| 99 | phagosome maturation (GO:0090382) | 2.68335063 |
| 100 | central nervous system myelination (GO:0022010) | 2.67870443 |
| 101 | axon ensheathment in central nervous system (GO:0032291) | 2.67870443 |
| 102 | response to peptidoglycan (GO:0032494) | 2.67742502 |
| 103 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.67003152 |
| 104 | proline transport (GO:0015824) | 2.66776654 |
| 105 | cysteine metabolic process (GO:0006534) | 2.66641601 |
| 106 | transferrin transport (GO:0033572) | 2.66391731 |
| 107 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.66317275 |
| 108 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.66054349 |
| 109 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65669622 |
| 110 | synaptic transmission, glutamatergic (GO:0035249) | 2.65483308 |
| 111 | tryptophan metabolic process (GO:0006568) | 2.65004842 |
| 112 | exploration behavior (GO:0035640) | 2.64934854 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.64917093 |
| 114 | regulation of oxidative phosphorylation (GO:0002082) | 2.64088951 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 2.63676497 |
| 116 | L-amino acid import (GO:0043092) | 2.62923853 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.61526092 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.60720564 |
| 119 | adenosine receptor signaling pathway (GO:0001973) | 2.60111966 |
| 120 | aldehyde catabolic process (GO:0046185) | 2.59874924 |
| 121 | regulation of complement activation (GO:0030449) | 2.59290093 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.58961480 |
| 123 | low-density lipoprotein particle remodeling (GO:0034374) | 2.58660717 |
| 124 | aromatic amino acid family metabolic process (GO:0009072) | 2.58046894 |
| 125 | serine family amino acid catabolic process (GO:0009071) | 2.57342925 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.56922021 |
| 127 | neuron-neuron synaptic transmission (GO:0007270) | 2.56740353 |
| 128 | tricarboxylic acid cycle (GO:0006099) | 2.55486726 |
| 129 | cyclooxygenase pathway (GO:0019371) | 2.54834502 |
| 130 | long-term memory (GO:0007616) | 2.54236077 |
| 131 | fatty acid elongation (GO:0030497) | 2.53857649 |
| 132 | ceramide catabolic process (GO:0046514) | 2.53289113 |
| 133 | cell communication involved in cardiac conduction (GO:0086065) | 2.52663830 |
| 134 | very long-chain fatty acid metabolic process (GO:0000038) | 2.52431120 |
| 135 | 2-oxoglutarate metabolic process (GO:0006103) | 2.52036830 |
| 136 | chaperone-mediated protein transport (GO:0072321) | 2.51727477 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 2.51657449 |
| 138 | cholesterol efflux (GO:0033344) | 2.51632347 |
| 139 | potassium ion import (GO:0010107) | 2.50811255 |
| 140 | reactive oxygen species biosynthetic process (GO:1903409) | 2.49542540 |
| 141 | activation of protein kinase A activity (GO:0034199) | 2.49066867 |
| 142 | reverse cholesterol transport (GO:0043691) | 2.48999315 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.48275444 |
| 144 | positive regulation of membrane potential (GO:0045838) | 2.46622967 |
| 145 | cellular sodium ion homeostasis (GO:0006883) | 2.46589359 |
| 146 | glutamine family amino acid catabolic process (GO:0009065) | 2.46556294 |
| 147 | regulation of fibrinolysis (GO:0051917) | 2.46390453 |
| 148 | purine nucleotide salvage (GO:0032261) | 2.45991409 |
| 149 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44928317 |
| 150 | negative regulation of blood coagulation (GO:0030195) | 2.44581709 |
| 151 | negative regulation of hemostasis (GO:1900047) | 2.44581709 |
| 152 | NADH metabolic process (GO:0006734) | 2.43939667 |
| 153 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.43816189 |
| 154 | amino sugar catabolic process (GO:0046348) | 2.43600699 |
| 155 | ferric iron transport (GO:0015682) | 2.43464107 |
| 156 | trivalent inorganic cation transport (GO:0072512) | 2.43464107 |
| 157 | ethanol oxidation (GO:0006069) | 2.42977781 |
| 158 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.42769394 |
| 159 | xenobiotic catabolic process (GO:0042178) | 2.42762159 |
| 160 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.42471657 |
| 161 | behavioral response to cocaine (GO:0048148) | 2.42443598 |
| 162 | hydrogen ion transmembrane transport (GO:1902600) | 2.41680554 |
| 163 | regulation of mast cell degranulation (GO:0043304) | 2.40768187 |
| 164 | nitrogen cycle metabolic process (GO:0071941) | 2.40764019 |
| 165 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.40640808 |
| 166 | protein activation cascade (GO:0072376) | 2.40101997 |
| 167 | alanine transport (GO:0032328) | 2.38007125 |
| 168 | macromolecular complex remodeling (GO:0034367) | 2.37916265 |
| 169 | negative regulation of interleukin-12 production (GO:0032695) | 2.37747068 |
| 170 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37020110 |
| 171 | ribosomal small subunit biogenesis (GO:0042274) | 2.35865254 |
| 172 | protein neddylation (GO:0045116) | 2.33609080 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32831935 |
| 174 | protein maturation by protein folding (GO:0022417) | 2.30789864 |
| 175 | lipoxygenase pathway (GO:0019372) | 2.30656427 |
| 176 | urea metabolic process (GO:0019627) | 2.30640756 |
| 177 | complement activation (GO:0006956) | 2.29391537 |
| 178 | viral transcription (GO:0019083) | 2.29355542 |
| 179 | negative regulation of coagulation (GO:0050819) | 2.28193755 |
| 180 | negative regulation of fibrinolysis (GO:0051918) | 2.28043214 |
| 181 | pentose metabolic process (GO:0019321) | 2.27962303 |
| 182 | GDP-mannose metabolic process (GO:0019673) | 2.27422596 |
| 183 | acute inflammatory response (GO:0002526) | 2.27085483 |
| 184 | oxaloacetate metabolic process (GO:0006107) | 2.26947568 |
| 185 | arginine catabolic process (GO:0006527) | 2.26866459 |
| 186 | ATP biosynthetic process (GO:0006754) | 2.26353134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.25308626 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.07786560 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.21546198 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79714813 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.78795295 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60263541 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.56365142 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55393934 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52036004 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.47289350 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.38402187 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28058266 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28058266 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.27162831 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26991216 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25861182 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25383539 |
| 18 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.24197519 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24126022 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22490866 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.21284074 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19806857 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18239588 |
| 24 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11533378 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11483906 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09963295 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07568018 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.04537069 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.00744126 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00713762 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00648261 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00555208 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99479777 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93476586 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93269289 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93141583 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91118359 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90606660 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89004819 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85530749 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85395381 |
| 42 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83888899 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81128280 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73199806 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72570703 |
| 46 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.71568250 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.70372269 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69216820 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61099656 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60229692 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.60154805 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59150872 |
| 53 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58200796 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56080280 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55869488 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.55344565 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55172631 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.52542974 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51889864 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51657893 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49780923 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49252534 |
| 63 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.48355461 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44628363 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41491848 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39921049 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38298973 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37916729 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36716252 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35794607 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34815681 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33557484 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32284344 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32012892 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31465068 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30796381 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30432737 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30392073 |
| 79 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.30145526 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30037766 |
| 81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28897281 |
| 82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28687572 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27630984 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27129998 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26614376 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25753685 |
| 87 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25664531 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25420173 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25333163 |
| 90 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23906553 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23595766 |
| 92 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.23579522 |
| 93 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23466951 |
| 94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23435813 |
| 95 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23181504 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22107698 |
| 97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21390443 |
| 98 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20731205 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19498679 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19255769 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16611586 |
| 102 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16260841 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16157530 |
| 104 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16129613 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15746933 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14840996 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14158154 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12451257 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12225640 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11863474 |
| 111 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.11370499 |
| 112 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10883128 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10597728 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09350237 |
| 115 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08406792 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08317278 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06496395 |
| 118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.06395913 |
| 119 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06364555 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05955314 |
| 121 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05774249 |
| 122 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05636771 |
| 123 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04985571 |
| 124 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04908908 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04905668 |
| 126 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04006939 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02584741 |
| 128 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02215776 |
| 129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01583829 |
| 130 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00174802 |
| 131 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99710115 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99561715 |
| 133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99439021 |
| 134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99378136 |
| 135 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99216055 |
| 136 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98671303 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98323893 |
| 138 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97974181 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97343933 |
| 140 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97210105 |
| 141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96860061 |
| 142 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96348218 |
| 143 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93170681 |
| 144 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92266922 |
| 145 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91927388 |
| 146 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91378944 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91264453 |
| 148 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90520841 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90071840 |
| 150 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89917356 |
| 151 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89535028 |
| 152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88479490 |
| 153 | AR_19668381_ChIP-Seq_PC3_Human | 0.86993175 |
| 154 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86521218 |
| 155 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86361609 |
| 156 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85430509 |
| 157 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84510524 |
| 158 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84228653 |
| 159 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80990070 |
| 160 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80700632 |
| 161 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79420594 |
| 162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77997289 |
| 163 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77795502 |
| 164 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77784054 |
| 165 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77239185 |
| 166 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.75891120 |
| 167 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75280546 |
| 168 | STAT3_23295773_ChIP-Seq_U87_Human | 0.75029799 |
| 169 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.74885208 |
| 170 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74271784 |
| 171 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.73824616 |
| 172 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73151150 |
| 173 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73055773 |
| 174 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72994116 |
| 175 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.72003137 |
| 176 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71885109 |
| 177 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.71584976 |
| 178 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.70772729 |
| 179 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68680627 |
| 180 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.68209349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.57546235 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.22599486 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.78529659 |
| 4 | MP0003880_abnormal_central_pattern | 3.46086914 |
| 5 | MP0005360_urolithiasis | 3.37714085 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.10618811 |
| 7 | MP0002822_catalepsy | 3.03957478 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.94298372 |
| 9 | MP0003303_peritoneal_inflammation | 2.78128133 |
| 10 | MP0005365_abnormal_bile_salt | 2.65496164 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.65177147 |
| 12 | MP0004270_analgesia | 2.62896935 |
| 13 | MP0009745_abnormal_behavioral_response | 2.60527074 |
| 14 | MP0002064_seizures | 2.56648354 |
| 15 | MP0009046_muscle_twitch | 2.46594905 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.35089777 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.31764731 |
| 18 | MP0003436_decreased_susceptibility_to | 2.29393414 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.28208031 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.25880378 |
| 21 | MP0002272_abnormal_nervous_system | 2.25365035 |
| 22 | MP0000343_altered_response_to | 2.22746313 |
| 23 | MP0004510_myositis | 2.13512411 |
| 24 | MP0001486_abnormal_startle_reflex | 2.05722385 |
| 25 | MP0009785_altered_susceptibility_to | 2.05185579 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 2.03340307 |
| 27 | MP0003329_amyloid_beta_deposits | 2.01422764 |
| 28 | MP0003195_calcinosis | 1.96503701 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.96130491 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.95460444 |
| 31 | MP0003186_abnormal_redox_activity | 1.92897020 |
| 32 | MP0003646_muscle_fatigue | 1.92384742 |
| 33 | MP0009278_abnormal_bone_marrow | 1.91505430 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.82905752 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.81696282 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.81696282 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.75390738 |
| 38 | MP0005025_abnormal_response_to | 1.75366138 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.73883915 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.73788681 |
| 41 | MP0005332_abnormal_amino_acid | 1.71553487 |
| 42 | MP0002419_abnormal_innate_immunity | 1.70015423 |
| 43 | MP0004142_abnormal_muscle_tone | 1.68137842 |
| 44 | MP0002736_abnormal_nociception_after | 1.62430317 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.59650145 |
| 46 | MP0006082_CNS_inflammation | 1.59354043 |
| 47 | MP0000751_myopathy | 1.58462480 |
| 48 | MP0001853_heart_inflammation | 1.56058791 |
| 49 | MP0005083_abnormal_biliary_tract | 1.54776163 |
| 50 | MP0003690_abnormal_glial_cell | 1.51858354 |
| 51 | MP0009764_decreased_sensitivity_to | 1.51469673 |
| 52 | MP0008260_abnormal_autophagy | 1.50181082 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.47964950 |
| 54 | MP0004043_abnormal_pH_regulation | 1.47768651 |
| 55 | MP0004885_abnormal_endolymph | 1.47593377 |
| 56 | MP0009840_abnormal_foam_cell | 1.47220968 |
| 57 | MP0008569_lethality_at_weaning | 1.46324222 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.44398460 |
| 59 | MP0005166_decreased_susceptibility_to | 1.44296936 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.41874812 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.39530959 |
| 62 | MP0008469_abnormal_protein_level | 1.38699702 |
| 63 | MP0001764_abnormal_homeostasis | 1.38448687 |
| 64 | MP0003724_increased_susceptibility_to | 1.38226278 |
| 65 | MP0003252_abnormal_bile_duct | 1.37120469 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.33248822 |
| 67 | MP0005451_abnormal_body_composition | 1.32797860 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.32767650 |
| 69 | MP0004924_abnormal_behavior | 1.32767650 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.31578810 |
| 71 | MP0001970_abnormal_pain_threshold | 1.31480119 |
| 72 | MP0000920_abnormal_myelination | 1.31014672 |
| 73 | MP0004036_abnormal_muscle_relaxation | 1.29588122 |
| 74 | MP0005387_immune_system_phenotype | 1.28654359 |
| 75 | MP0001790_abnormal_immune_system | 1.28654359 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.28564634 |
| 77 | MP0008004_abnormal_stomach_pH | 1.28411280 |
| 78 | MP0001835_abnormal_antigen_presentation | 1.27924143 |
| 79 | MP0004858_abnormal_nervous_system | 1.27171952 |
| 80 | MP0003633_abnormal_nervous_system | 1.24973075 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.24131972 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.24060413 |
| 83 | MP0004147_increased_porphyrin_level | 1.22533836 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 1.22392881 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 1.21048667 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.20958857 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19275243 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.19207581 |
| 89 | MP0003879_abnormal_hair_cell | 1.19070442 |
| 90 | MP0004215_abnormal_myocardial_fiber | 1.17828467 |
| 91 | MP0001529_abnormal_vocalization | 1.17718001 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.17211147 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.16588894 |
| 94 | MP0009379_abnormal_foot_pigmentation | 1.15422734 |
| 95 | MP0005535_abnormal_body_temperature | 1.15360177 |
| 96 | MP0002909_abnormal_adrenal_gland | 1.14833979 |
| 97 | MP0001905_abnormal_dopamine_level | 1.14164136 |
| 98 | MP0002132_abnormal_respiratory_system | 1.13898071 |
| 99 | MP0000604_amyloidosis | 1.13591617 |
| 100 | MP0000955_abnormal_spinal_cord | 1.12302425 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 1.10708460 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 1.10648114 |
| 103 | MP0008872_abnormal_physiological_respon | 1.09906747 |
| 104 | MP0004811_abnormal_neuron_physiology | 1.09819278 |
| 105 | MP0002229_neurodegeneration | 1.09280697 |
| 106 | MP0003631_nervous_system_phenotype | 1.08914818 |
| 107 | MP0000749_muscle_degeneration | 1.08018240 |
| 108 | MP0005671_abnormal_response_to | 1.07999385 |
| 109 | MP0002723_abnormal_immune_serum | 1.06524156 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 1.05740061 |
| 111 | MP0005330_cardiomyopathy | 1.04163883 |
| 112 | MP0002452_abnormal_antigen_presenting | 1.03451145 |
| 113 | MP0004085_abnormal_heartbeat | 1.01333311 |
| 114 | MP0004084_abnormal_cardiac_muscle | 1.00593665 |
| 115 | MP0002557_abnormal_social/conspecific_i | 0.99782576 |
| 116 | MP0009763_increased_sensitivity_to | 0.98387525 |
| 117 | MP0004130_abnormal_muscle_cell | 0.97755669 |
| 118 | MP0000778_abnormal_nervous_system | 0.97418680 |
| 119 | MP0008874_decreased_physiological_sensi | 0.96794272 |
| 120 | MP0002653_abnormal_ependyma_morphology | 0.96365837 |
| 121 | MP0002882_abnormal_neuron_morphology | 0.95754574 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.95242796 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.95127502 |
| 124 | MP0000609_abnormal_liver_physiology | 0.95098839 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.93355927 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.93218275 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.92798530 |
| 128 | MP0001502_abnormal_circadian_rhythm | 0.92098412 |
| 129 | MP0003011_delayed_dark_adaptation | 0.90972125 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.90016071 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.89478848 |
| 132 | MP0005165_increased_susceptibility_to | 0.88730785 |
| 133 | MP0000685_abnormal_immune_system | 0.88088869 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.87857837 |
| 135 | MP0003075_altered_response_to | 0.87321252 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.87124790 |
| 137 | MP0001819_abnormal_immune_cell | 0.86762974 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.86589904 |
| 139 | MP0002184_abnormal_innervation | 0.86084138 |
| 140 | MP0002420_abnormal_adaptive_immunity | 0.85920351 |
| 141 | MP0003634_abnormal_glial_cell | 0.85816781 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.85712980 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.85032588 |
| 144 | MP0001756_abnormal_urination | 0.84543156 |
| 145 | MP0003632_abnormal_nervous_system | 0.84274841 |
| 146 | MP0004947_skin_inflammation | 0.82954271 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.82900221 |
| 148 | MP0000747_muscle_weakness | 0.81879605 |
| 149 | MP0005310_abnormal_salivary_gland | 0.81747634 |
| 150 | MP0000858_altered_metastatic_potential | 0.81138882 |
| 151 | MP0002269_muscular_atrophy | 0.79245811 |
| 152 | MP0009642_abnormal_blood_homeostasis | 0.78186931 |
| 153 | MP0001984_abnormal_olfaction | 0.77924927 |
| 154 | MP0001485_abnormal_pinna_reflex | 0.77168429 |
| 155 | MP0001800_abnormal_humoral_immune | 0.77148545 |
| 156 | MP0004233_abnormal_muscle_weight | 0.77080685 |
| 157 | MP0006138_congestive_heart_failure | 0.76688855 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.76288874 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.75265252 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.74705000 |
| 161 | MP0005319_abnormal_enzyme/_coenzyme | 0.70010044 |
| 162 | MP0005620_abnormal_muscle_contractility | 0.69843440 |
| 163 | MP0002090_abnormal_vision | 0.69605841 |
| 164 | MP0001663_abnormal_digestive_system | 0.67293850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Myokymia (HP:0002411) | 5.39375096 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.28263332 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.83553088 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.83553088 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.83553088 |
| 6 | Focal motor seizures (HP:0011153) | 4.74490652 |
| 7 | Purpura (HP:0000979) | 4.39718077 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.07549459 |
| 9 | Petechiae (HP:0000967) | 3.74979370 |
| 10 | Glomerulonephritis (HP:0000099) | 3.62552537 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.55429742 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.55124055 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.41098717 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.35190653 |
| 15 | Pheochromocytoma (HP:0002666) | 3.35121461 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.33609967 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.28096386 |
| 18 | Focal seizures (HP:0007359) | 3.20218374 |
| 19 | Abnormality of complement system (HP:0005339) | 3.17577083 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17128549 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.12740967 |
| 22 | Increased serum ferritin (HP:0003281) | 3.08422391 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.07789164 |
| 24 | Ankle clonus (HP:0011448) | 3.04494896 |
| 25 | Hyperglycinemia (HP:0002154) | 3.01553063 |
| 26 | Mutism (HP:0002300) | 2.99240963 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97400208 |
| 28 | Hyperammonemia (HP:0001987) | 2.97093820 |
| 29 | Neuroendocrine neoplasm (HP:0100634) | 2.95224044 |
| 30 | Action tremor (HP:0002345) | 2.94692464 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.94237032 |
| 32 | Ketosis (HP:0001946) | 2.93889400 |
| 33 | Epileptic encephalopathy (HP:0200134) | 2.82695577 |
| 34 | Visual hallucinations (HP:0002367) | 2.82309360 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.80226538 |
| 36 | Joint hemorrhage (HP:0005261) | 2.79377731 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77074540 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77074540 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77074540 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 2.74779698 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.74779698 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.73608205 |
| 43 | Mitochondrial inheritance (HP:0001427) | 2.73416416 |
| 44 | Xanthomatosis (HP:0000991) | 2.69377702 |
| 45 | Hyperventilation (HP:0002883) | 2.66870378 |
| 46 | Hyperglycinuria (HP:0003108) | 2.64715468 |
| 47 | Atonic seizures (HP:0010819) | 2.64320902 |
| 48 | Abnormality of iron homeostasis (HP:0011031) | 2.64201134 |
| 49 | Progressive cerebellar ataxia (HP:0002073) | 2.63120184 |
| 50 | Hyperlipoproteinemia (HP:0010980) | 2.62160306 |
| 51 | Acute encephalopathy (HP:0006846) | 2.61710645 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.61082778 |
| 53 | Loss of speech (HP:0002371) | 2.59850442 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.58311999 |
| 55 | Cerebral edema (HP:0002181) | 2.56470463 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56211137 |
| 57 | Anxiety (HP:0000739) | 2.55350351 |
| 58 | Exercise-induced myalgia (HP:0003738) | 2.54950486 |
| 59 | Ketoacidosis (HP:0001993) | 2.54370021 |
| 60 | Dysmetria (HP:0001310) | 2.53299043 |
| 61 | Status epilepticus (HP:0002133) | 2.53050973 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.53045244 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.52974850 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.49896426 |
| 65 | Absence seizures (HP:0002121) | 2.49325674 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47513266 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.47513266 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.47480447 |
| 69 | Postural instability (HP:0002172) | 2.47292336 |
| 70 | Recurrent abscess formation (HP:0002722) | 2.46482537 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.45046629 |
| 72 | Gout (HP:0001997) | 2.44363876 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.42721266 |
| 74 | Cholecystitis (HP:0001082) | 2.42721266 |
| 75 | Prolonged neonatal jaundice (HP:0006579) | 2.41212877 |
| 76 | Abnormality of the lower motor neuron (HP:0002366) | 2.41007664 |
| 77 | Epistaxis (HP:0000421) | 2.40972521 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.40145582 |
| 79 | Dysdiadochokinesis (HP:0002075) | 2.39328995 |
| 80 | Sudden death (HP:0001699) | 2.38657145 |
| 81 | Febrile seizures (HP:0002373) | 2.37850177 |
| 82 | Axonal loss (HP:0003447) | 2.37136672 |
| 83 | Bundle branch block (HP:0011710) | 2.35632777 |
| 84 | Intention tremor (HP:0002080) | 2.32747425 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32512771 |
| 86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.32476390 |
| 87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.32476390 |
| 88 | Gingival bleeding (HP:0000225) | 2.31605464 |
| 89 | Nausea (HP:0002018) | 2.28884258 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.28030582 |
| 91 | Impaired social interactions (HP:0000735) | 2.27949019 |
| 92 | Abnormal social behavior (HP:0012433) | 2.27949019 |
| 93 | * Torticollis (HP:0000473) | 2.27626845 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 2.27597612 |
| 95 | * Focal dystonia (HP:0004373) | 2.26967907 |
| 96 | Spastic gait (HP:0002064) | 2.26634776 |
| 97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.26372809 |
| 98 | Increased CSF lactate (HP:0002490) | 2.26221849 |
| 99 | Dialeptic seizures (HP:0011146) | 2.24819290 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22116927 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.22022799 |
| 102 | Poor eye contact (HP:0000817) | 2.21120581 |
| 103 | Complement deficiency (HP:0004431) | 2.19235121 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 2.17993298 |
| 105 | Menorrhagia (HP:0000132) | 2.16850842 |
| 106 | Progressive neurologic deterioration (HP:0002344) | 2.15983098 |
| 107 | Obstructive lung disease (HP:0006536) | 2.15587596 |
| 108 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15587596 |
| 109 | Abnormality of lateral ventricle (HP:0030047) | 2.14658038 |
| 110 | * Craniofacial dystonia (HP:0012179) | 2.13759865 |
| 111 | Abnormal eating behavior (HP:0100738) | 2.12218999 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12023940 |
| 113 | Depression (HP:0000716) | 2.10344449 |
| 114 | Lethargy (HP:0001254) | 2.10237814 |
| 115 | Amyloidosis (HP:0011034) | 2.10096373 |
| 116 | Clonus (HP:0002169) | 2.08886962 |
| 117 | Cerebral hemorrhage (HP:0001342) | 2.08537482 |
| 118 | Hepatic necrosis (HP:0002605) | 2.05074299 |
| 119 | Syncope (HP:0001279) | 2.04019194 |
| 120 | Dicarboxylic aciduria (HP:0003215) | 2.03962221 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03962221 |
| 122 | Abnormal platelet function (HP:0011869) | 2.03875744 |
| 123 | Impaired platelet aggregation (HP:0003540) | 2.03875744 |
| 124 | Metabolic acidosis (HP:0001942) | 2.02722566 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 2.01138996 |
| 126 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99897002 |
| 127 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99820029 |
| 128 | Cholelithiasis (HP:0001081) | 1.99670100 |
| 129 | Heart block (HP:0012722) | 1.99506006 |
| 130 | Nephritis (HP:0000123) | 1.99415001 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 1.98467872 |
| 132 | Scanning speech (HP:0002168) | 1.97880847 |
| 133 | Sensorimotor neuropathy (HP:0007141) | 1.97563641 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.97474753 |
| 135 | Prolonged QT interval (HP:0001657) | 1.96502508 |
| 136 | Hypoglycemic coma (HP:0001325) | 1.95989645 |
| 137 | Leukodystrophy (HP:0002415) | 1.95760729 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 1.95713609 |
| 139 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93800214 |
| 140 | Urinary urgency (HP:0000012) | 1.93504387 |
| 141 | Increased circulating renin level (HP:0000848) | 1.92903691 |
| 142 | Recurrent bacterial skin infections (HP:0005406) | 1.92273217 |
| 143 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92067461 |
| 144 | Neonatal onset (HP:0003623) | 1.91418337 |
| 145 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91048991 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90349900 |
| 147 | Progressive macrocephaly (HP:0004481) | 1.90127000 |
| 148 | Myoglobinuria (HP:0002913) | 1.89677464 |
| 149 | Abnormality of the corticospinal tract (HP:0002492) | 1.89495817 |
| 150 | Hemiplegia (HP:0002301) | 1.89473168 |
| 151 | Spastic tetraparesis (HP:0001285) | 1.88848508 |
| 152 | Gaze-evoked nystagmus (HP:0000640) | 1.88474338 |
| 153 | Abnormality of methionine metabolism (HP:0010901) | 1.86742573 |
| 154 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.86656536 |
| 155 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86520428 |
| 156 | Tetraplegia (HP:0002445) | 1.86439709 |
| 157 | Respiratory failure (HP:0002878) | 1.86278789 |
| 158 | Exertional dyspnea (HP:0002875) | 1.85617112 |
| 159 | Opisthotonus (HP:0002179) | 1.85508633 |
| 160 | Ragged-red muscle fibers (HP:0003200) | 1.85159941 |
| 161 | Broad-based gait (HP:0002136) | 1.84921415 |
| 162 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82110701 |
| 163 | Joint swelling (HP:0001386) | 1.80591038 |
| 164 | Eczematoid dermatitis (HP:0000976) | 1.80291717 |
| 165 | Nuclear cataract (HP:0100018) | 1.78622341 |
| 166 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76927158 |
| 167 | Lactic acidosis (HP:0003128) | 1.76906323 |
| 168 | Dementia (HP:0000726) | 1.76869090 |
| 169 | Abnormal pupillary function (HP:0007686) | 1.75946318 |
| 170 | Paralysis (HP:0003470) | 1.74426178 |
| 171 | Retinal atrophy (HP:0001105) | 1.71040518 |
| 172 | Abnormality of renal resorption (HP:0011038) | 1.70057690 |
| 173 | Irritability (HP:0000737) | 1.69535245 |
| 174 | Glycosuria (HP:0003076) | 1.67660491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.61391767 |
| 2 | RIPK4 | 3.31003705 |
| 3 | EPHA4 | 3.29591643 |
| 4 | NTRK3 | 3.28177337 |
| 5 | ERN1 | 2.98232343 |
| 6 | MAP3K9 | 2.83467557 |
| 7 | IRAK3 | 2.81127425 |
| 8 | TESK2 | 2.66945106 |
| 9 | VRK2 | 2.55457895 |
| 10 | MAP3K4 | 2.49756163 |
| 11 | PRKD3 | 2.42869799 |
| 12 | PINK1 | 2.36831570 |
| 13 | MINK1 | 2.29134462 |
| 14 | TESK1 | 2.26464390 |
| 15 | BCKDK | 2.23552898 |
| 16 | DAPK2 | 2.17627678 |
| 17 | MAP2K4 | 2.11744142 |
| 18 | TAOK2 | 2.08857537 |
| 19 | PAK6 | 2.05849414 |
| 20 | MAP2K7 | 2.02469262 |
| 21 | LMTK2 | 1.96015786 |
| 22 | MATK | 1.93912681 |
| 23 | MAP3K12 | 1.93790614 |
| 24 | KSR2 | 1.89054145 |
| 25 | PHKG1 | 1.83380783 |
| 26 | PHKG2 | 1.83380783 |
| 27 | TBK1 | 1.80325666 |
| 28 | OXSR1 | 1.76923506 |
| 29 | PIM2 | 1.74495292 |
| 30 | MARK1 | 1.71195753 |
| 31 | STK16 | 1.67420857 |
| 32 | CAMKK1 | 1.63321599 |
| 33 | ABL2 | 1.62156358 |
| 34 | STK38 | 1.61782751 |
| 35 | BLK | 1.60864465 |
| 36 | ARAF | 1.58328877 |
| 37 | SGK223 | 1.53796183 |
| 38 | SGK494 | 1.53796183 |
| 39 | NTRK1 | 1.49382396 |
| 40 | STK39 | 1.46381526 |
| 41 | WNK4 | 1.40743065 |
| 42 | NTRK2 | 1.40095308 |
| 43 | TYK2 | 1.39161098 |
| 44 | CDK19 | 1.37763303 |
| 45 | MUSK | 1.37607089 |
| 46 | UHMK1 | 1.33889254 |
| 47 | WNK1 | 1.24979333 |
| 48 | CDK5 | 1.23681411 |
| 49 | MYLK | 1.22844224 |
| 50 | PDK4 | 1.21530714 |
| 51 | PDK3 | 1.21530714 |
| 52 | PRKCG | 1.21175185 |
| 53 | GRK5 | 1.20425150 |
| 54 | GRK7 | 1.19903258 |
| 55 | IKBKB | 1.19621841 |
| 56 | NEK1 | 1.19155811 |
| 57 | TAOK3 | 1.19131206 |
| 58 | MAP2K3 | 1.17028868 |
| 59 | MAP3K3 | 1.16872976 |
| 60 | CSF1R | 1.12853940 |
| 61 | CASK | 1.10235608 |
| 62 | PRPF4B | 1.09324928 |
| 63 | LRRK2 | 1.08036303 |
| 64 | CAMK2G | 1.05197014 |
| 65 | CAMK2A | 1.04412073 |
| 66 | DAPK1 | 1.03589223 |
| 67 | FGR | 1.03527784 |
| 68 | EIF2AK1 | 1.01655696 |
| 69 | IRAK2 | 1.01394338 |
| 70 | PDK2 | 1.00573020 |
| 71 | PRKG2 | 0.98575514 |
| 72 | TYRO3 | 0.97759603 |
| 73 | KDR | 0.97698919 |
| 74 | PAK3 | 0.96782908 |
| 75 | MAP4K1 | 0.95312370 |
| 76 | IKBKE | 0.94428173 |
| 77 | BMX | 0.93870739 |
| 78 | TRIB3 | 0.93868392 |
| 79 | FES | 0.93523193 |
| 80 | PDPK1 | 0.92964825 |
| 81 | MAPKAPK3 | 0.92275867 |
| 82 | CAMK2B | 0.89843977 |
| 83 | PRKCH | 0.89599216 |
| 84 | CCNB1 | 0.89279341 |
| 85 | SGK2 | 0.88938559 |
| 86 | CAMK1 | 0.88695583 |
| 87 | PKN1 | 0.88651656 |
| 88 | NEK6 | 0.88599121 |
| 89 | LATS2 | 0.87553267 |
| 90 | ICK | 0.87123497 |
| 91 | MAP3K13 | 0.85728959 |
| 92 | SGK3 | 0.85494970 |
| 93 | DDR2 | 0.84166351 |
| 94 | STK11 | 0.84158168 |
| 95 | NME1 | 0.84086291 |
| 96 | DAPK3 | 0.83876202 |
| 97 | MAP2K6 | 0.82882273 |
| 98 | SYK | 0.80440295 |
| 99 | PTK2B | 0.80309787 |
| 100 | WNK3 | 0.79132239 |
| 101 | PDK1 | 0.78833010 |
| 102 | MAPK13 | 0.78070072 |
| 103 | CDC42BPA | 0.77854940 |
| 104 | ZAP70 | 0.77562445 |
| 105 | TNIK | 0.77405315 |
| 106 | LIMK1 | 0.76966871 |
| 107 | KSR1 | 0.76699170 |
| 108 | CAMK2D | 0.76004748 |
| 109 | IRAK4 | 0.73590063 |
| 110 | PRKCZ | 0.72896202 |
| 111 | CDK15 | 0.72420202 |
| 112 | CDK18 | 0.72217360 |
| 113 | CAMKK2 | 0.71068537 |
| 114 | ILK | 0.69191840 |
| 115 | SIK1 | 0.69130811 |
| 116 | CDK14 | 0.68798463 |
| 117 | PLK2 | 0.67689784 |
| 118 | ADRBK2 | 0.66528462 |
| 119 | JAK3 | 0.64748393 |
| 120 | MAP3K2 | 0.62975805 |
| 121 | BCR | 0.62894625 |
| 122 | MAP3K7 | 0.62648315 |
| 123 | LYN | 0.62463343 |
| 124 | MAPK15 | 0.60647611 |
| 125 | GRK6 | 0.60580171 |
| 126 | CSK | 0.60455796 |
| 127 | CDK11A | 0.59310887 |
| 128 | TNK2 | 0.59208055 |
| 129 | TAOK1 | 0.58375838 |
| 130 | OBSCN | 0.58130390 |
| 131 | MAP3K5 | 0.57672922 |
| 132 | CAMK4 | 0.56364178 |
| 133 | MAP3K1 | 0.56005145 |
| 134 | PRKCE | 0.55283344 |
| 135 | ROCK2 | 0.54307003 |
| 136 | AKT3 | 0.53528536 |
| 137 | RET | 0.53433043 |
| 138 | VRK1 | 0.53394615 |
| 139 | PAK1 | 0.51765417 |
| 140 | PRKCD | 0.51302321 |
| 141 | MAPK12 | 0.51123092 |
| 142 | BRAF | 0.50869643 |
| 143 | SGK1 | 0.50853003 |
| 144 | PRKACG | 0.50845296 |
| 145 | RPS6KA3 | 0.50244187 |
| 146 | RIPK1 | 0.50115630 |
| 147 | MAP3K11 | 0.50022987 |
| 148 | ROCK1 | 0.49772751 |
| 149 | BRSK1 | 0.48877976 |
| 150 | PRKAA1 | 0.48073160 |
| 151 | CSNK1G2 | 0.47581059 |
| 152 | KIT | 0.46166231 |
| 153 | JAK2 | 0.42669420 |
| 154 | TGFBR2 | 0.42123701 |
| 155 | DYRK1B | 0.39445791 |
| 156 | SMG1 | 0.38027184 |
| 157 | PRKCA | 0.36286911 |
| 158 | CAMK1D | 0.35604816 |
| 159 | BTK | 0.35543487 |
| 160 | FYN | 0.34914691 |
| 161 | SCYL2 | 0.34793185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.79159579 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31785591 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.74656842 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71847312 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47802346 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36116072 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.28210849 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25131529 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.24377752 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21489154 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15285154 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13480182 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.99664695 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98282224 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97257587 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94946394 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.94800962 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.89432279 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85323913 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.83289212 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80477613 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.77682117 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69952435 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65408347 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.64583994 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58493845 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58493681 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55535515 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55445429 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54787019 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.51979538 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51546712 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48691076 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.48550309 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39688741 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.34590157 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.34176285 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33573414 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31687943 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.29413258 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28014230 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.27659100 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.23966733 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23608668 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22891387 |
| 46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.22245130 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19263407 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17736416 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17124842 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15313514 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14575902 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13230112 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12023549 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 1.10371531 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08258241 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05605081 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04343488 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03907054 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03561469 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03541434 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02691428 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01477774 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.99953687 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.99402617 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97257254 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97038094 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96296624 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95729747 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94416574 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93301561 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92794533 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91823205 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91736338 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91516828 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91153652 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90746398 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90617565 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90148040 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85528339 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85333472 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84957674 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83477294 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.80856330 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80355785 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79261185 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79145729 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79048775 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78882759 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77499411 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.77442249 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76132097 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75687466 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75267375 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74338507 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73784169 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73075722 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.72519703 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72260910 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70966916 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.68649540 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67614486 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62243625 |
| 103 | Malaria_Homo sapiens_hsa05144 | 0.60425599 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59691108 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59653848 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.58466948 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.57806896 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57649088 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.57421298 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56503100 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56330850 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55471447 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.54861837 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54479923 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54207438 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52292892 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52018644 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51534179 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.49557646 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48844706 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48724598 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.47715119 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.46193141 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44649910 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42580571 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41650936 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41170867 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39843574 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39622100 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39465005 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.38857485 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36968176 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36578230 |
| 134 | Allograft rejection_Homo sapiens_hsa05330 | 0.36276063 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35825485 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34145795 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33203714 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32884306 |
| 139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30997561 |
| 140 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.26622716 |
| 141 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26164686 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23902266 |
| 143 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23288355 |
| 144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20504820 |

